[6-K] MDJM LTD Current Report (Foreign Issuer)

Rhea-AI Filing Summary

MDJM LTD reports that Nasdaq has placed the company under a one-year Discretionary Panel Monitor starting from the letter dated November 19, 2025. This step follows Nasdaq’s prior confirmation that MDJM had maintained compliance with its listing rules through October 20, 2025, as required by a June 10, 2025 decision of a Nasdaq Hearings Panel.

During this one-year monitoring period, if MDJM fails to meet any continued listing requirement, Nasdaq’s Listing Qualifications Staff will issue a Delist Determination Letter. In that situation, MDJM would not be allowed to submit a new compliance plan, and the Staff would not be able to grant additional time for the company to regain compliance. This makes any future rule violation more likely to result directly in delisting.

Positive

• None.

Negative

• Nasdaq one-year Discretionary Panel Monitor raises delisting risk: any failure to meet continued listing requirements during the period will trigger a Delist Determination Letter without extra time or a new compliance plan.

Insights

Equity market structure and listing standards analyst

Nasdaq’s one-year discretionary monitor sharply tightens MDJM’s listing risk.

MDJM LTD remains listed but is now under a one-year Discretionary Panel Monitor imposed by a Nasdaq Hearings Panel pursuant to Listing Rule 5815(d)(4)(A). This follows earlier confirmation that the company had maintained compliance with Nasdaq’s listing rules through October 20, 2025, under a prior panel decision dated June 10, 2025.

Under the monitor, any failure to meet any continued listing requirement will cause Nasdaq’s Listing Qualifications Staff to issue a Delist Determination Letter. The company would not be permitted to present a plan of compliance for new deficiencies, and the Staff would not be allowed to grant more time to cure them, removing flexibility that many issuers normally have.

This framework means that the consequences of even a single listing-rule breach during the one-year period could be more immediate and severe than usual. The company’s ongoing compliance with all quantitative and qualitative Nasdaq standards during this monitor period will be critical, since any deficiency would move directly to a delisting determination step rather than a negotiated remediation path.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-38768

MDJM LTD

Fernie Castle, Letham

Cupar, Fife, KY15 7RU
United Kingdom
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x Form 40-F ¨

Nasdaq Imposes A One-Year Discretionary Panel Monitor On MDJM LTD

As previously reported on a Form 6-K filed with the U.S. Securities and Exchange Commission on October 31, 2025, MDJM LTD, a Cayman Islands company (the “Company”), received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), advising that the Company had maintained compliance with the Listing Rules of Nasdaq through October 20, 2025, as required by the June 10, 2025 decision issued by the Nasdaq Hearings Panel (the “Panel”).

Subsequently, the Company received a letter, dated November 19, 2025 (the “Letter”) from Nasdaq, advising that pursuant to its authority under Listing Rule 5815(d)(4)(A), the Panel had determined to impose a Discretionary Panel Monitor for a period of one year from the date of the Letter. If within that one-year monitoring period, the Company fails to maintain compliance with any continued listing requirement, the Listing Qualifications Department (the “Staff”) will issue a Delist Determination Letter and the Company will not be permitted to provide Staff with a plan of compliance with respect to any deficiency that arises during the monitor period. In addition, the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to any deficiency.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MDJM LTD
Date: November 25, 2025	By:	/s/ Siping Xu
	Name:	Siping Xu
	Title:	Chairman of the Board of Directors

2

FAQ

What did Nasdaq decide regarding MDJM LTD (UOKA) in this Form 6-K?

Nasdaq’s Hearings Panel imposed a one-year Discretionary Panel Monitor on MDJM LTD, starting from a letter dated November 19, 2025, under Listing Rule 5815(d)(4)(A).

Why is MDJM LTD (UOKA) under a Nasdaq Discretionary Panel Monitor?

MDJM LTD had previously been under a Nasdaq Hearings Panel decision dated June 10, 2025, and Nasdaq later confirmed the company maintained compliance through October 20, 2025, before deciding to place it under a one-year monitoring period.

What happens if MDJM LTD fails a Nasdaq listing requirement during the one-year monitor?

If MDJM fails to maintain any continued listing requirement during the monitor, Nasdaq’s Listing Qualifications Staff will issue a Delist Determination Letter with no opportunity to submit a new plan of compliance or obtain extra time.

Can MDJM LTD get additional time from Nasdaq to regain compliance during the monitor?

No. The filing states that during the one-year Discretionary Panel Monitor, the Staff will not be permitted to grant additional time for MDJM LTD to regain compliance for any new deficiency.

Does this Nasdaq action mean MDJM LTD (UOKA) is already delisted?

No. The company remains listed, but Nasdaq has put it under a one-year Discretionary Panel Monitor under which any new deficiency would lead directly to a Delist Determination Letter.

Who signed the MDJM LTD Form 6-K reporting the Nasdaq monitor decision?

The Form 6-K was signed on behalf of MDJM LTD by Siping Xu, who is identified as Chairman of the Board of Directors.